Benefits and considerations

Clinical trials offer many potential benefits to participants. As with any type of treatment, there are also potential disadvantages that patients should consider.

Potential Benefits:

  • Possibility that the treatment used will be better than currently approved treatments and access to treatments that may not otherwise be available.
  • Care and closer monitoring of the patient by top doctors and researchers at leading healthcare facilities.
  • Help to advance treatment of the disease.

Potential Disadvantages:

  • Possibility of unknown or unexpected side effects.
  • Chance that the new drug or treatment may be less effective than current options for pancreatic cancer.
  • May require greater time commitment due to extra clinic visits for treatments or monitoring.
  • There may be additional cost involved if the patient’s insurance does not cover routine care during clinical trials (see Common concerns about clinical trials) or if the patient needs to travel or relocate to participate in a specific clinical trial.

The Pancreatic Cancer Action Network’s Patient and Liaison Services (PALS) program maintains a comprehensive database containing up-to-date information about all pancreatic cancer clinical trials taking place in the United States. We offer personalized clinical trial searches so that patients can find trials for which they may be eligible.

Let us help you find a clinical trial that may be right for you!


The Pancreatic Cancer Action Network recommends that all patients consider clinical trials when exploring treatment options.

Clinical trials overview
Learn about pancreatic cancer clinical trials
How does a new treatment get FDA approval?
What rights and protections do participants have in a clinical trial?
Common concerns about clinical trials


Information provided by the Pancreatic Cancer Action Network, Inc. (“PanCAN”) is not a substitute for medical advice, diagnosis, treatment or other health care services. PanCAN may provide information to you about physicians, products, services, clinical trials or treatments related to pancreatic cancer, but PanCAN does not recommend nor endorse any particular health care resource. In addition, please note that any personal information you provide to PanCAN’s associates during telephone and/or email communications may be stored and used to help PanCAN achieve its mission of assisting patients with, and finding cures and treatments for, pancreatic cancer. Stored constituent information may be used to inform PanCAN programs and activities. Information also may be provided in aggregate or limited formats to third parties to guide future pancreatic cancer research and treatment efforts. PanCAN will not provide personal directly identifying information (such as your name or contact information) to such third parties without your prior written consent unless required or permitted by law to do so.